NCT02673437View on ClinicalTrials.gov

Rivaroxaban ACS Specialist Cohort Event Monitoring Study

CompletedOBSERVATIONAL
Enrollment

701

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

February 28, 2019

Study Completion Date

February 28, 2019

Conditions
Acute Coronary Syndrome
Interventions
OTHER

This is a non-interventional study

This is a non-interventional study

Trial Locations (2)

SO31 1AA

Drug Safety Research Unit (for data collation and analysis only), Southampton

Drug Safety Research Unit, Southampton

All Listed Sponsors
lead

Drug Safety Research Unit, Southampton, UK

OTHER

NCT02673437 - Rivaroxaban ACS Specialist Cohort Event Monitoring Study | Biotech Hunter | Biotech Hunter